The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,417–1,440 of 11,281
ArticleKetamine

Efficacy and safety of ketamine in total hip arthroplasty: a systematic review.

Xu T, Yang W, Chen L +7

Europe PMC2026
ArticleKetamine

Oral Prolonged-Release Ketamine for Treatment-Resistant Depression: Two Randomized Clinical Trials.

Walter M, Zu Eulenburg C, Damyanova A +8

Europe PMC2026
TrialPsilocybin

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

ClinicalTrials.gov2026
ArticleKetamine

Mu-Opioid Signaling Engagement as a Candidate Maintenance Mechanism for Prolonging Ketamine's Antisuicidal Effects.

Kvarta MD, Zarate CA Jr

Europe PMC2026
TrialKetamine

The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery

ClinicalTrials.gov2026
TrialLSD

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

ClinicalTrials.gov2026
TrialMDMA

Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls

ClinicalTrials.gov2026
ArticlePsilocybin

Toward an Optimal Framework for Psilocybin Regulation: A Comparison of State Regulatory Approaches Across Key Dimensions.

Saadoon D

Europe PMC2026
TrialKetamine

The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Non-inflatable Transoral Endoscopic Thyroid Surgery

ClinicalTrials.gov2026
ArticleDMT

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Uthaug MV, Lancelotta R, Szabo A +3

Europe PMC2026
ArticleLSD

Lysergic Acid Diethylamide (LSD)

Europe PMC1994
TrialKetamine

Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment

ClinicalTrials.gov2026
ArticleKetamine

Initiating dextromethorphan-bupropion extended release in patients with major depressive disorder: Delphi panel expert consensus recommendations.

Clayton AH, Alva G, Bowman P +7

Europe PMC2026
ArticlePsychedelics

A Missing Voice? Peer Support Workers' Perceptions of Psychedelic-Assisted Therapy in Australia: A Cross-Sectional Survey.

Lau AA, Arunogiri S, Raner-Galutera B +2

Europe PMC2026
ArticleKetamine

The effect of treatments for postpartum depression on breastfeeding practices: a systematic review and meta-analysis.

Shen S, Wang B, Zhao Y +2

Europe PMC2026
ArticleKetamine

Analgesia in Tactical Combat Casualty Care (TCCC): TCCC Guideline Change 25-03.

Barbee GA, Byrne BT, Clayton CE +21

Europe PMC2026
ArticlePsychedelics

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice.

Kim J, Lochhead L, Weissman CR

Europe PMC2026
ArticlePsychedelics

Correction: Psychedelic therapeutics in psychiatric conditions.

Harvey PD, Nemeroff CB

Europe PMC2026
ProjectPsychedelics

Mental health practioner (MHP) attitudes, moral injury, and willingness to use psychedelic-assisted therapy (PAT)

OSF2026
ArticlePsychedelics

Exploring Knowledge, Attitudes and Openness toward Psychedelics among Medical and Psychology Students in a Conservative Cultural Setting.

Albaik M, Shaikh AH, Kadi H +3

Europe PMC2026
ArticlePsychedelics

Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study.

Chwyl C, Ladka MS, Black JC +4

Europe PMC2026
Article5-MeO-DMT

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Cubala WJ, Bajbouj M, Bauer M +30

Europe PMC2026
DatasetKetamine

Data from: <em>In vivo</em> changes in zebrafish anesthetic sensitivity in response to the loss of kif5Aa are associated with the alteration of mitochondrial motility

Victoria Bedell, Roderic Eckenhoff

Dryad2026
ArticlePsychedelics

Explainable Artificial Intelligence (xAI) for 5-HT&lt;sub&gt;2A&lt;/sub&gt; Receptor Binding Affinity of New Psychoactive Substances.

Schöning V, Grafinger KE, Pasin D +3

Europe PMC2026